Selçuk Şahin

Selçuk Şahin

Auto-generated profile, based on publicly available information

Selçuk Şahin

Urology Department, Istinye University, Istanbul 34010, Turkey

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2015 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
SSS Sahin
S Sahin
MBM Bicer
M Bicer
GEG A Eren
G A Eren
STS Tas
S Tas
VTV Tugcu
V Tugcu
MCM Cek
M Cek

1 July 2011 in Urology
Verified
Journal Article
Closed access
ATAli Ihsan Taşçı
Ali Ihsan Taşçı
YIYusuf Özlem İlbey
Yusuf Özlem İlbey
HLHüseyin Luleci
Hüseyin Luleci
OCOlcay Cicekler
Olcay Cicekler
SSSelcuk Sahin
Selcuk Sahin
VTVolkan Tugcu
Volkan Tugcu

1 January 2016 in Urology Research and Practice
Verified
Journal Article
Open access
SASüheyla Apaydın
Süheyla Apaydın
VTVolkan Tuğcu
Volkan Tuğcu
NŞNevzat Can Şener
Nevzat Can Şener
SŞSelçuk Şahin
Selçuk Şahin
AYAbdullah Hizir Yavuzsan
Abdullah Hizir Yavuzsan
FAFATIH GOKHAN AKBAY
FATIH GOKHAN AKBAY
Objective: Robotic kidney transplantation, first described by Hoznek and colleagues, and has been improved by investigators like Oberholzer and Menon. We realized the first robotic kidney transplant (RKT) in our clinic in December 2015. In this study, we aimed to present the first 15 cases we performed within 3 months. Materıal and methods: Starting from January 2016, we performed 15 RKTs in our hospital. Before surgery, the whole robotic procedure was thoroughly explained to the patients and their informed consents were taken. Results: We performed RKT in 7 male and 8 female patients. Mean patient age was 37.4±10.8 years. Mean body mass index of the patients was 22.6±3.35 kg/m². Mean preoperative creatinine and hemoglobin levels were 6.14±2.12 mg/dL and 10.04±1.64 g/dL, respectively. Mean operative time was 300.3±104.2 minutes. Mean warm ischemia and re-warming times were 1.9±0.54 minutes and 73.3±30.7 minutes, respectively. We did not need any necessity to switch to open surgery, and any intraoperative complication did not develop in any patient. Lymphocele which is one of the most frequently encountered complications was not observed in our series. Conclusion: We think that using a minimally invasive approach greater number of patients will be able to benefit from this treatment modality, and this important health issue may decrease significantly.

1 January 2019 in Urology Research and Practice
Verified
Journal Article
Closed access
SŞSelçuk Şahin
Selçuk Şahin
MYMustafa Gürkan Yenice
Mustafa Gürkan Yenice
VTVolkan Tuğcu
Volkan Tuğcu
OAOktay Akça
Oktay Akça
AŞAbdulmuttalip Şimşek
Abdulmuttalip Şimşek
ATAli İhsan Taşçı
Ali İhsan Taşçı
Objective: We compared the outcomes of robotic-assisted radical perineal prostatectomy (r-PRP) versus robotic-assisted transperitoneal laparoscopic radical prostatectomy (RARP). Material and methods: Between November 2016 and September 2017 in our center, 40 patients underwent r-PRP, and 40 patients underwent RARP. All patients also underwent multiparametric magnetic resonance imaging (mpMRI) to exclude the cases with locally advanced disease. Patients with localized prostate cancer (C–T2N0M0) were included in the study. The exclusion criteria were contraindications for undergoing robotic radical prostatectomy; the Gleason score ≥4+3; extracapsular extension proven on biopsy or suspected on mpMRI; clinical stage ≥T2c; required pelvic lymph dissection according to Partin’s normogram; previous radiation therapy; hormonal therapy; any previous prostatic, urethral, or bladder neck surgery; and preoperative urinary incontinence or erectile dysfunction. Patients were placed in the exaggerated lithotomy position with 15° Trendelenburg for r-PRP and 40° Trendelenburg for RARP. Results: The mean age for the r-PRP and RARP groups were 61.2 (46–73) and 62.2 (50–75) years, respectively. The mean body mass index was significantly higher in the r-PRP group (p=0.02). The mean procedure duration time was 169.4 (100–255) minutes for the r-PRP group and 173.1 (130–210) minutes for the RARP group. The mean console time and anastomosis time were significantly lower for the r-PRP group. The mean estimated blood loss was significantly lower for the r-PRP group (p=0.002). Immediate continence rates in the r-PRP and RARP groups following the urethral catheter removal were 42% and 35% (p=0.30), respectively. Continence rates increased to 94.2% in the r-PRP and 72% in RARP (p=0.001) group at the 6th month, and to 95% in the r-PRP and 85.2% in RARP (p=0.02) group at the 9th month follow-up period. According to the International Index of Erectile Function-5 (IIEF-5), the erectile function rates at the 3-, 6-, and 9-month follow-up in the r-PRP group were 44%, 66%, and 75%, respectively. The rates in the RARP group at the 3-, 6-, and 9-month follow-up were 25%, 42%, and 66% (p=0.001), respectively. Conclusion: In our experience, r-PRP has acceptable morbidity, excellent surgical and pathological outcomes, and satisfactory oncologic and functional results compared to RARP. Cite this article as: Tuğcu V, Akça O, Şimşek A, Yiğitbaşı İ, Şahin S, Yenice MG, et al. Robotic-assisted perineal versus transperitoneal radical prostatectomy: A matched-pair analysis. Turk J Urol 2019; 45(4): 265-72.

27 January 2020 in BJU International
Verified
Journal Article
Closed access
PDF file
VTVolkan Tuğcu
Volkan Tuğcu
MEMithat Ekşi
Mithat Ekşi
SSSelcuk Sahin
Selcuk Sahin
YÇYunus Çolakoğlu
Yunus Çolakoğlu
ASAbdulmuttalip Simsek
Abdulmuttalip Simsek
ATAli İhsan Taşçı
Ali İhsan Taşçı

30 March 2020 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MYMustafa Gürkan Yenice
Mustafa Gürkan Yenice
YDYavuz Onur Danacioglu
Yavuz Onur Danacioglu
MMMeral Mert
Meral Mert
PKPınar Karakaya
Pınar Karakaya
KSKamil Gokhan Seker
Kamil Gokhan Seker
ATAli Ihsan Taşçı
Ali Ihsan Taşçı
Our objective in this study was to evaluate the factors predicting female sexual dysfunction (FSD) in patients with diabetes mellitus (DM). The study included 149 women with DM. Sexual function was evaluated with the Female Sexual Function Index (FSFI) questionnaire, in which total scores under 26.55 characterized the occurrence of FSD (Group 1 > 26.55, Group 2 < 26.55). We recorded the patients' demographic, metabolic, and hormonal data. Ophthalmologic, neurologic, and renal complications were also evaluated. The antioxidant status of the patients in both groups was determined by measuring the activity of the enzymes paraoxonase-1 (PON-1) and arylesterase (ARE). Based on the FSFI scores, 60 patients were allocated to Group 1 (26.6 ± 12.3) and 89 to Group 2 (22.6 ± 9.5). Group 2 compared with Group 1 had significantly (p < 0.05) higher mean concentrations of glycated hemoglobin (HbA1c), glucose, triglycerides, and insulin, along with higher rates of metformin use, smoking, retinopathy, and nephropathy. The mean serum ARE concentrations were significantly lower in Group 2 compared with Group 1 (p = 0.000), but the mean serum PON-1 concentrations were similar between both groups (p = 0.218). On multivariable regression analysis, age, ARE activity, Beck Depression Inventory (BDI) score, and menopause were significant independent predictors of FSD (p < 0.05). In this study, we evaluated the predictive factors determining FSD caused by DM. Despite the significant results found in our study, future randomized controlled studies with a long follow-up and a larger number of patients are required to determine how DM affects FSD.